Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing

Tina Moore

👤 Person
4863 total appearances

Appearances Over Time

Podcast Appearances

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

With ingredients like DIM, glucoraphanin, milk thistle, NAC, alpha lipoic acid, turmeric, and more, Liver Love supports phase one and phase two liver function, antioxidant activity, and cellular health. So your body has the foundation it needs to function its best. This is not a cheap cleanse.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

This is a clinical grade formula that I've used for years in practice and it's designed for women who take their health seriously. Head to store.drtina.com to check it out now. While you're there, use code LIVER20 for 20% off and let me know what you think. That's Liver Love, my premium product to support detox, hormone metabolism, and whole body resilience.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

This is a clinical grade formula that I've used for years in practice and it's designed for women who take their health seriously. Head to store.drtina.com to check it out now. While you're there, use code LIVER20 for 20% off and let me know what you think. That's Liver Love, my premium product to support detox, hormone metabolism, and whole body resilience.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

This is a clinical grade formula that I've used for years in practice and it's designed for women who take their health seriously. Head to store.drtina.com to check it out now. While you're there, use code LIVER20 for 20% off and let me know what you think. That's Liver Love, my premium product to support detox, hormone metabolism, and whole body resilience.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

So this article is called Cardioprotective Glucose Lowering Agents and Dementia Risk, a systematic review and meta-analysis. It's in JAMA Neurology, published April 7th, 2025. So pretty brand new. And you guys can grab this for free online and look it over. It's laid out well. It's got the study broken down on the first page. It's got some key points to look at. And I think it's very interesting.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

So this article is called Cardioprotective Glucose Lowering Agents and Dementia Risk, a systematic review and meta-analysis. It's in JAMA Neurology, published April 7th, 2025. So pretty brand new. And you guys can grab this for free online and look it over. It's laid out well. It's got the study broken down on the first page. It's got some key points to look at. And I think it's very interesting.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

So this article is called Cardioprotective Glucose Lowering Agents and Dementia Risk, a systematic review and meta-analysis. It's in JAMA Neurology, published April 7th, 2025. So pretty brand new. And you guys can grab this for free online and look it over. It's laid out well. It's got the study broken down on the first page. It's got some key points to look at. And I think it's very interesting.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

And I... From what I am sitting in, in the waist-high, neck-high piles of data that I've looked at, these peptides are pretty incredible on the neurologic system. I'll share a little bit more with you and then we'll close. The mechanisms of action, the way that GLP-1s work in the brain is that they decrease.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

And I... From what I am sitting in, in the waist-high, neck-high piles of data that I've looked at, these peptides are pretty incredible on the neurologic system. I'll share a little bit more with you and then we'll close. The mechanisms of action, the way that GLP-1s work in the brain is that they decrease.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

And I... From what I am sitting in, in the waist-high, neck-high piles of data that I've looked at, these peptides are pretty incredible on the neurologic system. I'll share a little bit more with you and then we'll close. The mechanisms of action, the way that GLP-1s work in the brain is that they decrease.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

pro-inflammatory cytokines, interleukin-6, TNF-alpha, interleukin-1-beta, they increase mitochondrial biogenesis and fatty acid oxidation, they increase endothelial repair and neurovascular support, they decrease microglial and astrocyte activation, they increase neurotrophic signaling, i.e. BDNF, they increase serotonergic and dopaminergic tone.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

pro-inflammatory cytokines, interleukin-6, TNF-alpha, interleukin-1-beta, they increase mitochondrial biogenesis and fatty acid oxidation, they increase endothelial repair and neurovascular support, they decrease microglial and astrocyte activation, they increase neurotrophic signaling, i.e. BDNF, they increase serotonergic and dopaminergic tone.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

pro-inflammatory cytokines, interleukin-6, TNF-alpha, interleukin-1-beta, they increase mitochondrial biogenesis and fatty acid oxidation, they increase endothelial repair and neurovascular support, they decrease microglial and astrocyte activation, they increase neurotrophic signaling, i.e. BDNF, they increase serotonergic and dopaminergic tone.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I can't think of anything else aside from exercise that has anywhere close to the impacts on the brain. If you're not keen on taking a GLP-1 or that's not something that's accessible to you, because right now the lawsuits are, it's crazy what's happening with the lawsuits. I'm just trying to stay out of all of it. There are some other options.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I can't think of anything else aside from exercise that has anywhere close to the impacts on the brain. If you're not keen on taking a GLP-1 or that's not something that's accessible to you, because right now the lawsuits are, it's crazy what's happening with the lawsuits. I'm just trying to stay out of all of it. There are some other options.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I can't think of anything else aside from exercise that has anywhere close to the impacts on the brain. If you're not keen on taking a GLP-1 or that's not something that's accessible to you, because right now the lawsuits are, it's crazy what's happening with the lawsuits. I'm just trying to stay out of all of it. There are some other options.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I just did a really interesting podcast with a woman named Sarah Kennedy who is the CEO and founder of CaloCurb. It's a GLP-1 stimulant supplement and fascinating, really fascinating interview. So I encourage you, that was just recently recorded and published, so I encourage you to go back and listen to that episode as well. We'll put that in the show notes in the further listening section.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I just did a really interesting podcast with a woman named Sarah Kennedy who is the CEO and founder of CaloCurb. It's a GLP-1 stimulant supplement and fascinating, really fascinating interview. So I encourage you, that was just recently recorded and published, so I encourage you to go back and listen to that episode as well. We'll put that in the show notes in the further listening section.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

I just did a really interesting podcast with a woman named Sarah Kennedy who is the CEO and founder of CaloCurb. It's a GLP-1 stimulant supplement and fascinating, really fascinating interview. So I encourage you, that was just recently recorded and published, so I encourage you to go back and listen to that episode as well. We'll put that in the show notes in the further listening section.

The Dr. Tyna Show
GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty

And I've got a whole Ozempic Done Right series of podcasts that you can listen to where I talk about... a variety, and this is all for you guys, a variety of different implications, bones, the muscles, I've already talked about that. I don't need to do another episode on that. So go back and listen to all of that.